Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Regímenes de vigilancia ecográfica en embarazos gemelares para mejorar los resultados

Información

DOI:
https://doi.org/10.1002/14651858.CD011371.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 noviembre 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Embarazo y parto

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Jane G Woolcock

    Correspondencia a: Women's and Babies' Division, Discipline of Obstetrics and Gynaecology, The University of Adelaide, Women's and Children's Hospital, Adelaide, Australia

    [email protected]

  • Rosalie M Grivell

    Department of Obstetrics and Gynaecology, Flinders University and Flinders Medical Centre, Bedford Park, Australia

  • Jodie M Dodd

    School of Paediatrics and Reproductive Health, Discipline of Obstetrics and Gynaecology, The University of Adelaide, Women's and Children's Hospital, Adelaide, Australia

Contributions of authors

J Woolcock (JW) is the contact person and guarantor for the review. J Woolcock developed and wrote the background and methods of the protocol and co‐ordinated the protocol development.

R Grivell provided advice from a clinical and methodological perspective. R Grivell and J Woolcock checked the studies for inclusion and independently extracted data from the included study.

J Dodd provided advice from a clinical and methodological perspective.

Declarations of interest

J Woolcock : none known.

R Grivell : none known.

J Dodd : none known.

Acknowledgements

As part of the pre‐publication editorial process, four peers (an editor and three referees who are external to the editorial team), a member of Cochrane Pregnancy and Childbirth's international panel of consumers and the Group's Statistical Adviser commented on this review.

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Pregnancy and Childbirth. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2017 Nov 07

Regimens of ultrasound surveillance for twin pregnancies for improving outcomes

Review

Jane G Woolcock, Rosalie M Grivell, Jodie M Dodd

https://doi.org/10.1002/14651858.CD011371.pub2

2014 Nov 12

Regimens of ultrasound surveillance for twin pregnancies for improving outcomes

Protocol

Jane G Woolcock, Rosalie M Grivell, Jodie M Dodd

https://doi.org/10.1002/14651858.CD011371

Differences between protocol and review

There are some differences between our published protocol (Woolcock 2014) and the full review ‐ these are listed below.

We added an additional search of ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP).

We have updated our methods in line with the standard methods of Cochrane Pregnancy and Childbirth, this includes methods for dealing with outcome data from multiple pregnancies, the use of GRADE and inclusion of summary of findings Table for the main comparison.

Keywords

MeSH

Medical Subject Headings Check Words

Female; Humans; Infant, Newborn; Pregnancy;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Study flow diagram
Figuras y tablas -
Figure 1

Study flow diagram

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 1 Perinatal mortality (post randomisation).
Figuras y tablas -
Analysis 1.1

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 1 Perinatal mortality (post randomisation).

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 2 Stillbirth.
Figuras y tablas -
Analysis 1.2

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 2 Stillbirth.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 3 Neonatal death.
Figuras y tablas -
Analysis 1.3

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 3 Neonatal death.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 4 Gestational age at birth.
Figuras y tablas -
Analysis 1.4

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 4 Gestational age at birth.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 5 Infant requiring ventilation.
Figuras y tablas -
Analysis 1.5

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 5 Infant requiring ventilation.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 6 Admission to special care or intensive care units.
Figuras y tablas -
Analysis 1.6

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 6 Admission to special care or intensive care units.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 7 Caesarean section any.
Figuras y tablas -
Analysis 1.7

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 7 Caesarean section any.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 8 Elective caesarean section.
Figuras y tablas -
Analysis 1.8

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 8 Elective caesarean section.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 9 Emergency caesarean section.
Figuras y tablas -
Analysis 1.9

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 9 Emergency caesarean section.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 10 Induction of labour.
Figuras y tablas -
Analysis 1.10

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 10 Induction of labour.

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 11 Antenatal admission to hospital.
Figuras y tablas -
Analysis 1.11

Comparison 1 Fetal growth (biometry) + umbilical artery Doppler versus fetal growth, Outcome 11 Antenatal admission to hospital.

Summary of findings for the main comparison. Fetal growth (biometry) + umbilical artery Doppler versus fetal growth for twin pregnancies for improving outcomes

Fetal growth + umbilical artery Doppler versus fetal growth for twin pregnancies for improving outcomes

Patient or population: women with twin pregnancies were randomised from 25 weeks
Setting: tertiary level referral hospitals in Australia, New Zealand and South West Asia
Intervention: fetal growth plus Doppler
Comparison: fetal growth

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Risk with fetal growth + umbilical artery Doppler

Risk with fetal growth

Perinatal mortality

(after randomisation)

Study population

RR 0.88
(0.32 to 2.41)

1052
(1 RCT)

⊕⊕⊝⊝
Low1

15 per 1000

13 per 1000
(5 to 37)

Neonatal death

Study population

RR 1.01
(0.29 to 3.46)

1052
(1 RCT)

⊕⊕⊝⊝
Low1

9 per 1000

10 per 1000
(3 to 33)

Birth less than 28 weeks

The trial included in this review did not report this outcome.

Gestational age at birth (weeks)

The mean gestational age at birth was 35.8 weeks

The mean gestational age at birth was 35.7 weeks

MD 0.10 weeks longer with growth plus Doppler
(0.39 shorter to 0.59 longer)

526
(1 RCT)

⊕⊕⊕⊝
Moderate2

Caesarean section (any)

Study population

RR 1.00
(0.81 to 1.23)

526
(1 RCT)

⊕⊕⊕⊕
High

409 per 1000

409 per 1000
(331 to 503)

Induction of labour

Study population

RR 1.10
(0.80 to 1.50)

526
(1 RCT)

⊕⊕⊕⊝
Moderate3

216 per 1000

238 per 1000
(173 to 324)

Antenatal admission to hospital

Study population

RR 0.96
(0.80 to 1.15)

526
(1 RCT)

⊕⊕⊕⊕
High

477 per 1000

458 per 1000
(382 to 549)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio

GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect

1 Events are rare and wide confidence intervals cross line of no effect (‐2).
2 Confidence limits cross line of no effect and 0.5 in both directions (‐1).
3 Wide confidence intervals crossing line of no effect (‐1).

Figuras y tablas -
Summary of findings for the main comparison. Fetal growth (biometry) + umbilical artery Doppler versus fetal growth for twin pregnancies for improving outcomes
Comparison 1. Fetal growth (biometry) + umbilical artery Doppler versus fetal growth

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Perinatal mortality (post randomisation) Show forest plot

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.32, 2.41]

2 Stillbirth Show forest plot

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

0.67 [0.11, 3.99]

3 Neonatal death Show forest plot

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.29, 3.46]

4 Gestational age at birth Show forest plot

1

526

Mean Difference (IV, Fixed, 95% CI)

0.10 [‐0.39, 0.59]

5 Infant requiring ventilation Show forest plot

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.86 [0.59, 1.25]

6 Admission to special care or intensive care units Show forest plot

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.88, 1.05]

7 Caesarean section any Show forest plot

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

1.00 [0.81, 1.23]

8 Elective caesarean section Show forest plot

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.77, 1.47]

9 Emergency caesarean section Show forest plot

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.66, 1.32]

10 Induction of labour Show forest plot

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

1.10 [0.80, 1.50]

11 Antenatal admission to hospital Show forest plot

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.80, 1.15]

Figuras y tablas -
Comparison 1. Fetal growth (biometry) + umbilical artery Doppler versus fetal growth